A new study revealed that “serious adverse events” are associated with mifepristone.Abortion medication. ”
According to Mayo Clinic, Mifepristone is a “pregnancy blocker” used in combination with misoprostol, another drug therapy to end pregnancy.
It is also used to manage early miscarriages as it helps prepare the body to empty the uterus.
A study by the Center for Ethics and Public Policy in Washington, DC, found that the rate of severe side effects is 22 times higher than that shown on FDA-approved drug labels.
Research summary shows that approximately 11% of women (more than one in 10) reported experiencing “infection, bleeding, or another serious or life-threatening adverse event” after undergoing abortion supported by Mifepristone.
The new study exposed a “serious adverse event” related to mifepristone, also known as “abortion drugs.” (istock)
This study used insurance claim data containing over 865,000 Medication abortion It is defined between 2017 and 2023, and as a result, it is described as the largest dataset for chemical abortion.
“In contrast, the current FDA-approved drug labels are based on the results of 10 clinical trials in a total of 30,966 women, of which less than 0.5% reportedly experienced severe disease. Side effects“The research says.
“Some of these exams were conducted 42 years ago.”
The research authors – Jamie Brian Hall, Director of Data Analytics at EPPC, and Ryan T. Anderson, President of EPPC, called the results “a truly shocking and sad reality.”
The study used more than 865,000 medication abortion claim data as stipulated between 2017 and 2023.
“These findings include the removal of critical FDA safety protections needed, particularly when Obama and the Biden administrations were first approved, as other studies in a smaller dataset discovered serious safety issues with chemical abortion drugs. The authors said in a statement sent to Fox News Digital.
“The biggest limitation we’re working on is that there’s no insurance code for death. Sadly, we know that. Women die from complications Abortion medication results. ”
Research summary shows that almost 11% of women report experiencing “infection, bleeding, or another serious or life-threatening adverse event.” (istock)
Based on the study, the researchers have revived the original safety protections they needed when they approved Mifepristone, telling the FDA that “women deserve the truth.”
Christina Francis, MD, CEO of the US Pro Life Obgyns Association, is based in Fort. Wayne, Indiana, was not involved in the study, but commented on the importance of the results.
Click here to get the Fox News app
“The findings of this study are consistent with what we saw in our 20 years of practice as OB-Gyn, analysing drug-induced abortions of about 900,000 people, and have been caring for many women who have lied about the safety of abortion drugs and suffered from considerable complications,” she told Fox News Digital.
Based on the number of Guttmacher Institute, Francis concluded that nearly 71,000 women in 2023 likely suffered from these types of severe complications.
Mifepristone is also used to manage early miscarriages as it helps prepare the body to empty the uterus. (istock)
“This should serve as a wake-up call for the FDA, where complication rates are more than 20 times higher than previously mentioned, and it’s a public health crisis that should be investigated soon,” she said.
“Women deserve informed consent of the potentially life-threatening dangers of these drugs.”
Potential limitations
Professor Jesse Hill, a health law expert at Case Western Reserve University in Cleveland, Ohio, also reviewed the findings.
She said that since it was approved in the US 25 years ago, Mifepristone has been one of the most studied drugs since claiming it was also “one of the safest ones.”
Click here to sign up for our health newsletter
Hill noted that EPPC studies have not been peer-reviewed and questioned its “potential bias.”
“This survey uses insurance claim data, but the insurance claim is an incomplete proxy Causal medical outcomes“She told Fox News Digital, “They often lack context. For example, the claims of bleeding may not be causally related to Mifepristone itself.”
According to the Guttmacher Institute, approximately 63% of all abortions in the United States in 2023 were medication abortions. (istock)
Hill also opposed to comparing the latest claims data with FDA clinical trial data.
“Clinical trials There are strict criteria for defining and reporting adverse events. Claim data is generated for claims rather than scientific analysis, and often overcounts or misclassifies events. ”
“A claim is an incomplete proxy for causal medical outcomes.”
Hill also noted that the FDA’s legal standard for drug regulation is not “risk-free,” and that all drugs have an adverse event rate.
“The risk of exaggerating without considering benefits distorts the regulatory framework,” she said.
For health articles, please visit www.foxnews.com/health
According to the Guttmacher Institute, approximately 63% of all abortions in the United States in 2023 were medication abortions. This is up from 53% in 2020.
Fox News Digital reached out to the FDA and the makers of Mifepristone for comment.
